Clinical Trial Update: An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for CoviVac evaluating prophylactic efficacy and immunogenicity/safety in coronavirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• COVIVAC

Snippet

Sponsor: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | Conditions: Coronavirus Infections, Vaccine | Phase 3 | Status: UNKNOWN